Medical, FDA DSHEA & FTC Affiliate Disclosure for breathizendirect.com
Statements on breathizendirect.com have not been evaluated by the U.S. Food and Drug Administration. Breathizen is a botanical dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease, nor to replace prescribed asthma or COPD inhalers.
1. FDA DSHEA Structure/Function & Non-Substitution Notice (21 CFR 101.93)
Every clinical citation on breathizendirect.com (including studies on Verbascum thapsus, Zingiber officinale, Citrus limon, and vegetable glycerin) is presented solely to evaluate the scientific plausibility and dose proportionality of the printed 154 mg blend. Breathizen has never been evaluated in a clinical trial as a finished commercial product. Never discontinue or reduce prescribed bronchodilators, inhaled corticosteroids, or other medications without consulting your physician [51].
2. FTC Commercial Affiliate Relationship Disclosure (16 CFR Part 255)
In compliance with the Federal Trade Commission Guides Concerning the Use of Endorsements and Testimonials in Advertising (16 CFR Part 255) [53], breathizendirect.com discloses that when a visitor clicks an outbound allocation link (such as /claim-allocation/?pack=6) and completes a purchase on the BuyGoods checkout page, our desk may receive an affiliate referral commission at zero extra cost to the buyer.
3. Testimonial & Review Verification Disclosure (16 CFR Part 465)
In compliance with 16 CFR Part 465 [54], we disclose that the four customer quotes displayed on the vendor's website (forbreathizen.com) carry a vendor footnote stating that names and identifying details were changed to protect privacy and that individual results vary.